PRESS RELEASE published on 03/26/2026 at 15:23, 4 months 14 days ago Sartorius AG - Resolutions of the Annual General Meeting Sartorius AG's Annual General Meeting results approved dividend of 0.74 euros per preference share and 0.73 euros per ordinary share. Next financial reports in April, July, and October 2026 Annual General Meeting Dividend Financial Reports Biopharmaceutical Sartorius AG
BRIEF published on 03/17/2026 at 07:04, 4 months 23 days ago Sartorius Intensifies Biopharma Strategy with Ambitious Growth Targets Operational Efficiency Growth Targets Bioprocess Solutions Sales Revenue Growth Biopharma Strategy
BRIEF published on 03/17/2026 at 07:04, 4 months 23 days ago Sartorius intensifie sa stratégie biopharmaceutique avec des objectifs de croissance ambitieux Croissance Du Chiffre D'affaires Efficacité Opérationnelle Objectifs De Croissance Solutions De Bioprocédés Stratégie Biopharmaceutique
PRESS RELEASE published on 03/17/2026 at 06:59, 4 months 23 days ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets at Capital Markets Day in Göttingen, Germany Sartorius Strategy Capital Markets Day Growth Targets Biopharma Focus
BRIEF published on 03/16/2026 at 14:09, 4 months 24 days ago Sartorius Unveils New Platform to Enhance Cell Therapy Production Cost Reduction Manufacturing Efficiency Cell Therapy Platform Eveo Launch Sartorius Innovation
BRIEF published on 03/16/2026 at 14:09, 4 months 24 days ago Sartorius dévoile une nouvelle plateforme pour améliorer la production de thérapie cellulaire Réduction Des Coûts Efficacité De Production Sartorius Innovation Plateforme De Thérapie Cellulaire Lancement D'Eveo
PRESS RELEASE published on 03/16/2026 at 14:04, 4 months 24 days ago Sartorius launches next-generation platform to boost efficiency in cell therapy production Sartorius launches next-generation platform for efficient cell therapy production, enabling cost reduction and scalability. Integrated system addresses manufacturing challenges Sartorius Cell Therapy Production Efficiency Manufacturing Costs Eveo Platform
BRIEF published on 02/16/2026 at 10:41, 5 months 21 days ago Sartorius Enhances Climate Targets with SBTi Validation Net-zero Emissions Sartorius Sustainable Energy Science Based Targets Climate Targets
BRIEF published on 02/16/2026 at 10:41, 5 months 21 days ago Sartorius renforce ses objectifs climatiques grâce à la validation SBTi Sartorius Énergie Durable Émissions Nettes Nulles Objectifs Climatiques Objectifs Fondés Sur La Science
PRESS RELEASE published on 02/16/2026 at 10:36, 5 months 21 days ago Sartorius sharpens climate targets and receives validation from Science Based Targets initiative Sartorius sharpens climate targets with Science Based Targets initiative validation, aiming for net-zero emissions by 2045. Transitioning to renewable energy & sustainable practices Net-zero Emissions SBTi Sartorius Climate Targets Science-based
Published on 08/07/2026 at 23:15, 2 days 3 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 3 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 days 4 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 days 4 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/10/2026 at 00:05, 2 hours 39 minutes ago Games of the Future Astana 2026 Comes to a Close After 12 Electric Days of Competition
Published on 08/09/2026 at 15:05, 11 hours 39 minutes ago GearUP and Escape from Tarkov Partner to Enhance Online Gaming Experience for the New Season
Published on 08/08/2026 at 16:25, 1 day 10 hours ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 2 days 3 hours ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 18:54, 2 days 7 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 2 days 7 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 days 8 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 2 days 8 hours ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 2 days 8 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
